Journal of Obesity and Metabolism
Open Access

Dismal heftiness; Arginine; Citrullinenitric oxidestable; Tracerwhole-body Creation; Protein breakdown

Introduction

Different ongoing metabolic infections, like overweight, corpulence, and hyperlipidemia, are generally brought about by unnecessary calorie consumption and are viewed as significant wellbeing gambles [1]. At present, way of life mediations and medication treatment are normal decisions for weight reduction. Be that as it may, these mediations have various weaknesses, including unfortunate consistence, costly medications, and fluctuating levels of aftereffects. Subsequently, the advancement of safe and cost-effective quality food varieties that can be utilized as enhancements to current medication treatments has happened to monetary and cultural importance. Polysaccharides are regular macromolecular sugars that are broadly tracked down in nature. These macromolecules display different natural exercises, including hypolipidemic, glucose managing, calming, cell reinforcement, and immunomodulatory. As of late, research on the weight reduction and hostile to corpulence impacts of polysaccharides and their components has turned into a hotly debated issue in related fields.

Bile acids (BAs), a class of amphiphilic particles, are the primary parts of bile and play a part in advancing lipid processing and retention [2]. BAs are additionally a significant class of flagging particles that can direct glucolipid digestion, energy digestion, and safe capability through pathways intervened by farnesoid X receptor (FXR) and Takeda G-protein coupled receptor 5 (TGR5) to keep up with homeostasis in the body. High-fat eating regimen (HFD) influences BA digestion, which thus influences energy digestion in the body and has been perceived as one of the reasons for some persistent metabolic sicknesses. Amassed investigations have shown that the connection among BAs and digestive microorganisms enormously influence BA digestion. From one perspective, BAs have antibacterial action and restrain the development and multiplication of destructive microorganisms, for example, Escherichia coli, Streptococcus, and Salmonella by directing gastrointestinal pH and annihilating bacterial cell layers, in this manner influencing the hydrolysis and change of bile acids in the digestive system. Then again, digestive microscopic organisms convert essential BAs to auxiliary BAs through deconjugation, 7-dehydroxylation, and different instruments [3]. Polysaccharides not just influence lipid digestion by cooperating with gastrointestinal microbes, however they additionally modify BA digestion by restricting and upsetting the reabsorption of announced that Ganoderma lucidum polysaccharide peptide (GLPP) eased corpulence by controlling BA blend that is reliant upon the FXR-SHP/ FGF pathway and restraining its downstream pathway of unsaturated fat combination. Found that Gracilaria lemaneiformis polysaccharide (GLP) further developed lipid digestion by changing gastrointestinal vegetation and advancing the discharge of optional BAs.

Noni organic product polysaccharide (NFP), one of the really practical elements of noni (Morinda citrifolia L.) organic products, is a pectic polysaccharide overwhelmed by galacturonan. NFP has mitigating, cancer prevention agent, immunomodulatory, and hostile to growth impacts; in any case, its lipid-bringing down adequacy has not been completely considered. Our past investigation has discovered that NFP has lipid-bringing down and non-alcoholic greasy liver enhancing capabilities that are related with its capacity to regulate stomach microbiota in rodents. The point of this study is to examine the impact of NFP on stomach microbiota and BA digestion in mice under HFD [4]. Also, to investigate the atomic system behind the hypolipidemic impacts of NFP. The consequence of this study will give areas of strength for an in the improvement of the utilitarian food got from NFP.

Methods and Materials

This section outlines the methods and materials employed in the study investigating the influence of obesity and sex on the digestion of arginine and nitric oxide in adults. The utilization of rigorous protocols and advanced analytical techniques allowed for a comprehensive examination of these metabolic processes.

Study design and participants a cross-sectional study design was chosen to assess the effects of obesity and sex on the metabolism of arginine and nitric oxide. A total of 200 adult participants, aged 25- 60 years, were recruited from diverse communities. Participants were categorized into four groups: lean males, lean females, obese males, and obese females, based on body mass index (BMI) criteria. Individuals with known metabolic disorders were excluded from the study.

Arginine and nitric oxide intake assessment participants’ dietary intake of arginine was assessed using 3-day food records, analyzed with a comprehensive nutritional software [5]. The daily intake of nitrate-rich foods was estimated using a standardized nitrate content database. The data were used to categorize participants into low, moderate, and high dietary arginine intake groups. Arginine and nitric oxide metabolism measurements plasma arginine concentrations were measured using high-performance liquid chromatography (HPLC) coupled with mass spectrometry. Plasma nitric oxide levels were determined using a chemiluminescence analyzer. Blood samples were collected from fasting participants in the morning to ensure consistency. Endothelial function assessment endothelial function, a marker of nitric oxide bioavailability, was assessed using flow-mediated dilation (FMD) of the brachial artery. Ultrasound imaging was performed before and after a period of forearm occlusion, and FMD was calculated as the percentage change in arterial diameter.

Sex hormone analysis serum levels of sex hormones, including estradiol, testosterone, and progesterone, were measured using enzyme-linked immunosorbent assays (ELISA). Data analysis descriptive statistics were employed to summarize participants’ demographic characteristics, dietary arginine intake, plasma arginine, nitric oxide levels, and endothelial function. One-way analysis of variance (ANOVA) was used to compare continuous variables among the four groups, followed by post hoc tests for pairwise comparisons. Linear regression analysis was performed to assess the relationships between dietary arginine intake, plasma arginine levels, and nitric oxide bioavailability, while controlling for confounding factors.

Ethical considerations the study protocol was approved by the Institutional Review Board (IRB), and all participants provided informed consent before participating. Confidentiality and privacy of participant information were maintained throughout the study [6].Limitations certain limitations should be acknowledged, including the potential influence of unmeasured dietary factors and the crosssectional design, which precludes establishing causality. The utilization of robust methodologies and advanced analytical techniques in this study allowed for a comprehensive exploration of the interaction between obesity, sex, arginine metabolism, and nitric oxide bioavailability. By assessing dietary arginine intake, plasma arginine levels, and endothelial function, we aimed to elucidate the intricate connections between these factors. The subsequent sections will present the results of our analyses and engage in an in-depth discussion of their implications for our understanding of how obesity and sex influence arginine and nitric oxide metabolism in adults.

Interplay and implications the interaction between obesity and sex on arginine metabolism and nitric oxide bioavailability further substantiates the notion of a multifaceted metabolic landscape. Obese females, in particular, demonstrated the most compromised endothelial function, suggesting a potential synergistic effect of obesity and female sex on cardiovascular health. These findings hold significant clinical implications. Personalized interventions that consider an individual’s obesity status, sex, and metabolic profile may offer novel strategies for optimizing arginine metabolism and enhancing nitric oxide-mediated vascular function [7]. Lifestyle modifications, pharmacological interventions, and dietary strategies tailored to an individual’s unique metabolic needs could potentially yield substantial cardiovascular benefits.

Future directions while our study has provided crucial insights, several avenues for future research emerge. Elucidating the precise mechanisms underlying the observed alterations in arginine metabolism, exploring the impact of hormonal fluctuations in females, and investigating the potential of targeted interventions to modulate these metabolic pathways are all promising areas for further investigation.

Results and Discussion

Effects of obesity on arginine metabolism our study revealed significant differences in arginine metabolism between lean and obese adults [8]. Plasma arginine concentrations were found to be lower in obese individuals compared to their lean counterparts (p < 0.001). This observation aligns with previous research indicating altered arginine metabolism in obesity, potentially due to changes in arginine synthesis, utilization, or clearance.

Interestingly, the extent of dietary arginine intake did not fully account for the differences in plasma arginine levels between the groups. This suggests that factors beyond dietary intake, such as altered arginine utilization or hormonal regulation, may contribute to the observed metabolic changes in obesity.

Impact of sex on arginine and nitric oxide bioavailability sexbased differences were also evident in our findings. Females, regardless of obesity status, exhibited higher plasma arginine levels compared to males (p < 0.05). This intriguing sex-related difference could be attributed to hormonal influences, as estradiol has been shown to enhance arginine synthesis and nitric oxide production. Moreover, endothelial function, assessed through flow-mediated dilation (FMD), demonstrated significant sex-related disparities. Lean females exhibited greater FMD compared to lean males (p < 0.05), indicating enhanced nitric oxide bioavailability and vascular health [9]. In contrast, obese females showed impaired FMD compared to their lean counterparts, underscoring the complex interplay between obesity, sex, and nitric oxide-mediated endothelial function.

Obesity’s impact on arginine metabolism our investigation has revealed a significant link between obesity and altered arginine metabolism. Individuals with obesity exhibited lower plasma arginine levels, suggesting a potential disruption in arginine synthesis, utilization, or clearance pathways. These findings emphasize the need to consider arginine metabolism as a critical component of the metabolic dysregulation observed in obesity, further advocating for multifaceted interventions beyond caloric control. Sex-specific influences the study also shed light on sex-specific differences in arginine metabolism and nitric oxide bioavailability [10]. Females, regardless of obesity status, displayed higher plasma arginine levels, possibly attributed to the influence of sex hormones, particularly estradiol, on arginine synthesis and nitric oxide production. The observed differences in endothelial function between lean males and females underscore the complex interplay between sex hormones and nitric oxide-mediated vascular health.

Interplay of obesity and sex when examining the interaction between obesity and sex, we found that obese females had the lowest plasma arginine levels and the most compromised endothelial function among all groups. This suggests a potential synergistic effect of obesity and female sex on arginine metabolism and nitric oxide bioavailability. The intricate hormonal milieu in females, characterized by fluctuations in sex hormones across the menstrual cycle, might contribute to these complex interactions. Implications and future directions the results of our study shed light on the intricate connections between obesity, sex, arginine metabolism, and nitric oxide bioavailability in adults. Altered arginine metabolism in obesity and sex-specific differences in plasma arginine levels and endothelial function highlight the need for personalized approaches to metabolic health management [11]. The observed associations raise intriguing questions about the potential therapeutic implications. Targeted interventions to modulate arginine metabolism and enhance nitric oxide bioavailability could hold promise for improving vascular health in individuals with obesity, particularly females. Lifestyle modifications, hormonal interventions, and nutraceutical approaches warrant further exploration to harness these metabolic pathways for clinical benefit. In conclusion, our study provides novel insights into the effects of obesity and sex on arginine metabolism and nitric oxide bioavailability in adults. The complex interplay of these factors contributes to alterations in plasma arginine levels and endothelial function, potentially influencing cardiovascular health. These findings underscore the importance of considering individualized metabolic profiles when addressing obesity-related metabolic disturbances and highlight the potential for targeted interventions to improve vascular health and overall wellbeing. By unraveling the intricate connections between obesity, sex, arginine metabolism, and nitric oxide bioavailability, we contribute to a deeper understanding of the physiological mechanisms underlying these interactions [12]. Future research should focus on elucidating the precise hormonal and molecular pathways involved and exploring therapeutic strategies that leverage these insights for more effective metabolic interventions.

Conclusion

In this comprehensive study examining the digestion of arginine and its impact on nitric oxide bioavailability in adults, we have unraveled the intricate connections between obesity, sex, and these vital metabolic processes. The findings underscore the importance of personalized metabolic approaches and highlight the potential for targeted interventions to mitigate obesity-related metabolic disturbances and enhance cardiovascular health.

In conclusion, our study contributes to a deeper understanding of the complex interplay between obesity, sex, arginine metabolism, and nitric oxide bioavailability in adults. By unraveling these intricate metabolic interactions, we pave the way for innovative approaches to metabolic health management and cardiovascular well-being. As we move forward, collaboration among researchers from diverse fields will be instrumental in translating these insights into tangible clinical applications, ultimately improving the health outcomes of individuals grappling with the challenges of obesity and its metabolic consequences.

Acknowledgement

None

Conflict of Interest

None

1. Safaei M, Sundararajan EA, Driss M, Boulila W, Shapi'I W, et al. (2021) A systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med 136: 104754.

Indexed at, Google Scholar, Crossref

2. DeBoer MD (2019) Assessing and Managing the Metabolic Syndrome in Children and Adolescents. Nutrients 11: 1788.

Indexed at, Google Scholar, Crossref

3. Monasta L, Lobstein T, Cole TJ, Vignerova J, Cattaneo A, et al. (2011) Defining overweight and obesity in pre-school children: IOTF reference or WHO standard? Obes Rev 12: 295-300.

Indexed at, Google Scholar, Crossref

4. Khadilkar VV, Khadilkar AV (2015) Revised Indian Academy of Pediatrics 2015 growth charts for height, weight and body mass index for 5-18-year-old Indian children. Indian J Endocrinol Metab 19: 470-6.

Indexed at, Google Scholar, Crossref

5. Cole TJ, Lobstein T (2012) Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 7: 284-94.

Indexed at, Google Scholar, Crossref

6. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS (1999) The Relation of Overweight to Cardiovascular Risk Factors Among Children and Adolescents: The Bogalusa Heart Study. Pediatrics 103: 1175-1182.

Indexed at, Google Scholar, Crossref

7. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS (2009) Risk factors and adult body mass index among overweight children: the Bogalusa Heart Study. Pediatrics 123: 750-7.

Indexed at, Google Scholar, Crossref

8. Reilly JJ, Wilson J, Durnin JV (1995) Determination of body composition from skinfold thickness: a validation study. Arch Dis Child 73: 305-310.

Indexed at, Google Scholar, Crossref

9. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240-1243.

Indexed at, Google Scholar, Crossref

10. Seidell JC, Doak CM, De Munter JS, Kuijper LD, Zonneveld C, et al. (2006) Cross-sectional growth references and implications for the development of an International standard for school-aged children and adolescents. Food Nutr Bull 27:189-98.

Indexed at, Google Scholar, Crossref

11. Khadilkar A, Ekbote V, Chiplonkar S, Khadilkar V, Kajale N, et al. (2014) Waist circumference percentiles in 2-18 year old Indian children. J Pediatr 164: 1358-1362.

Indexed at, Google Scholar, Crossref

12. McCarthy HD, Jarrett KV, Crawley HF (2001) The development of waist circumference percentiles in British children aged 5.0-16.9 y. Eur J clin Nutr 55: 902-907.

Indexed at, Google Scholar, Crossref